Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Murphy KathleenDirector | Grant or award | A | — 36 sh | Oct 2, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $394K 954 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Ellerbrook Michael MPresident, UFP Construction | Grant or award | A | $1,158 15 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | McIntosh Alice MartinsEVP, President of Industrials | Tax withholding | F | $9,063 214 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Tyler JamesDirector | Grant or award | A | — 11.3K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $766K 1,846 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Freda FabrizioDirector | Grant or award | A | — 18 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Daley PamelaDirector | Grant or award | A | — 27 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Bazar Gregory MatthewDirector | Grant or award | A | — 11.3K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Peck Kristin CDirector | Grant or award | A | — 30 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Menziuso Richard ThomasPrincipal Accounting Officer | Grant or award | A | — 36.2K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Trofimuk-O'Connor Christina AliceChief Legal Officer | Grant or award | A | — 3,228 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Dawson Bruce NeilChief Sales and CS Officer | Grant or award | A | — 3,228 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Martin SebastienDirector | Option exercise | M | — 198 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | VanAllen CherylEVP & CHIEF PEOPLE OFFICER | Grant or award | A | $4,616 50 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Nardi ScottSVP, Risk & Compliance Officer | Grant or award | A | $250 3 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Hegeman John WilliamDirector | Grant or award | A | — 144 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Guerre Robert PaulSecretary, Dir Corp Compliance | Grant or award | A | $1,467 19 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Robbins CharlesDirector | Grant or award | A | — 27 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Blizard JeffreyDirector | Grant or award | A | — 11.3K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Mumford Gregory J.D.Chief Financial Officer | Option exercise | M | — 17.1K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Ford William EDirector | Grant or award | A | — 34 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Ravichandran VidyaDirector | Grant or award | A | $11K 115 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Nasser Amin H.Director | Grant or award | A | — 27 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Philip Ron MDirector | Grant or award | A | $14K 1,109 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 9 | Vestberg Hans ErikDirector | Grant or award | A | — 33 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 8 | Dameron CliftonSVP, GC & Corporate Secretary | Tax withholding | F | $68K 1,420 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 8 | Dawson Bruce NeilChief Sales and CS Officer | Tax withholding | F | $61K 1,413 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 8 | Casteel Julie KChief Sales/Marketing Officer | Tax withholding | F | $55K 1,271 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 8 | Afdahl David MartinChief Operating Officer | Tax withholding | F | $69K 1,590 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 8 | Trofimuk-O'Connor Christina AliceChief Legal Officer | Tax withholding | F | $50K 1,159 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $446K 3,882 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Schubach Sarah ElizabethChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $66K 2,025 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 6 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 751 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 7,218 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 1,066 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Abdelsadek MohamedEVP, Chief Global Solutions | Open-market sale · 10b5-1 plan | SELL | $16K 250 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Raghavan VaidyanathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $56K 549 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $82K 200 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 5 | Darwal Michael JosephChief AI & Digital Officer | Tax withholding | F | $36K 843 sh | Oct 2, 2026 traded Sep 30, 2026 |